{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:12:17Z","timestamp":1768266737814,"version":"3.49.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Nerve Growth Factor (NGF) is a pivotal mediator of chronic pain and plays a role in bone remodelling. Through its high affinity receptor TrkA, NGF induces substance P (SP) as key downstream mediator of pain and local inflammation. Here we analysed NGF, TrkA and SP tissue distribution in facet joint osteoarthritis (FJOA), a major cause of chronic low back pain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>FJOA specimens (<jats:italic>n=<\/jats:italic>19) were harvested from patients undergoing intervertebral fusion surgery. Radiologic grading of FJOA and spinal stenosis, followed by immunohistochemistry for NGF, TrkA and SP on consecutive tissue sections, was performed in ten specimens. Explant cultures (<jats:italic>n<\/jats:italic>=9) were used to assess secretion of NGF, IL-6, and SP by FJOA osteochondral tissues under basal and inflammatory conditions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>NGF was predominantly expressed in damaged cartilaginous tissues (80%), occasionally in bone marrow (20%), but not in osteochondral vascular channels. NGF area fraction in cartilage was not associated with the extent of proteoglycan loss or radiologic FJOA severity. Consecutive sections showed that NGF and SP expression was localized at structurally damaged cartilage, in absence of TrkA expression. SP and TrkA were expressed in subchondral bone marrow in both presence and absence of NGF. Low level NGF, but not SP secretion, was detected in four out of eighteen FJOA explants under both basal or inflammatory conditions (<jats:italic>n<\/jats:italic>=2 each).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NGF is associated with SP expression and structural cartilage damage in osteoarthritic facet joints, but not with radiologic disease severity. NGF tissue distribution in FJOA differs from predominant subchondral bone expression reported for knee OA.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.783076","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T08:04:10Z","timestamp":1646121850000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Localization of Nerve Growth Factor Expression to Structurally Damaged Cartilaginous Tissues in Human Lumbar Facet Joint Osteoarthritis"],"prefix":"10.3389","volume":"13","author":[{"given":"Matthias F.","family":"Seidel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Netzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Chobaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"H\u00fcgle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Geurts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2009.03.002","article-title":"Nerve Growth Factor in Rheumatic Diseases","volume":"40","author":"Seidel","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.1.649","article-title":"Nerve Growth Factor Stimulates the Development of Substance P in Sensory Ganglia","volume":"77","author":"Kessler","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"B3","article-title":"Substance P Activates and Modulates Neutrophil Oxidative Metabolism and Aggregation","volume":"16","author":"Hafstrom","year":"1989","journal-title":"J\u00a0Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/art.40820","article-title":"Associations of Symptomatic Knee Osteoarthritis With Histopathologic Features in Subchondral Bone","volume":"71","author":"Aso","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.12.1413","article-title":"Increased Expression of Nerve Growth Factor (NGF) and High Affinity NGF Receptor (P140 TrkA) in Human Osteoarthritic Chondrocytes","volume":"41","author":"Iannone","year":"2002","journal-title":"Rheumatol (Oxford)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2015.06.009","article-title":"Characterization of Degenerative Human Facet Joints and Facet Joint Capsular Tissues","volume":"23","author":"Kim","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.joca.2015.06.012","article-title":"Intra-Articular Nerve Growth Factor Regulates Development, But Not Maintenance, of Injury-Induced Facet Joint Pain & Spinal Neuronal Hypersensitivity","volume":"23","author":"Kras","year":"2015","journal-title":"Osteoarthr Cartil"},{"key":"B8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41584-020-00528-4","article-title":"The Evolution of Nerve Growth Factor Inhibition in Clinical Medicine","volume":"17","author":"Wise","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11926-017-0665-5","article-title":"Rapidly Progressive Osteoarthritis: A Review of the Clinical and Radiologic Presentation","volume":"19","author":"Flemming","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216296","article-title":"Subcutaneous Tanezumab for Osteoarthritis of the Hip or Knee: Efficacy and Safety Results From a 24-Week Randomised Phase III Study With a 24-Week Follow-Up Period","volume":"79","author":"Berenbaum","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217259","article-title":"Efficacy and Safety of Fasinumab in Patients With Chronic Low Back Pain: A Phase II\/III Randomised Clinical Trial","volume":"80","author":"Dakin","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s002560050503","article-title":"MR Imaging and CT in Osteoarthritis of the Lumbar Facet Joints","volume":"28","author":"Weishaupt","year":"1999","journal-title":"Skeletal Radiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e3181d359bd","article-title":"Qualitative Grading of Severity of Lumbar Spinal Stenosis Based on the Morphology of the Dural Sac on Magnetic Resonance Images","author":"Schizas","year":"2010","journal-title":"Spine (Phila Pa"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051314","article-title":"Novel Ex Vivo Human Osteochondral Explant Model of Knee and Spine Osteoarthritis Enables Assessment of Inflammatory and Drug Treatment Responses","volume":"19","author":"Geurts","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13237","article-title":"Inflammation in Osteoarthritis: Is It Time to Dampen the Alarm(in) in This Debilitating Disease","volume":"195","author":"van den Bosch","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4108","article-title":"Analysis of the Mechanism by Which Nerve Growth Factor Promotes Callus Formation in Mice With Tibial Fracture","volume":"13","author":"Sang","year":"2017","journal-title":"Exp Ther Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2014.12.005","article-title":"TGF-Beta Is a Potent Inducer of Nerve Growth Factor in Articular Cartilage via the ALK5-Smad2\/3 Pathway. Potential Role in OA Related Pain","volume":"23","author":"Blaney Davidson","year":"2015","journal-title":"Osteoarthr Cartil"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/art.39523","article-title":"Nociceptive Sensitizers Are Regulated in Damaged Joint Tissues, Including Articular Cartilage, When Osteoarthritic Mice Display Pain Behavior","volume":"68","author":"Driscoll","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.675900","article-title":"Nerve Growth Factor Is Regulated by Toll-Like Receptor 2 in Human Intervertebral Discs","volume":"291","author":"Krock","year":"2016","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201900970","article-title":"Role of NGF-TrkA Signaling in Calcification of Articular Chondrocytes","volume":"33","author":"Jiang","year":"2019","journal-title":"FASEB J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13075-015-0840-x","article-title":"Cartilage Stem\/Progenitor Cells Are Activated in Osteoarthritis via Interleukin-1beta\/Nerve Growth Factor Signaling","volume":"17","author":"Jiang","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jor.23281","article-title":"Characterization of Subchondral Bone Histopathology of Facet Joint Osteoarthritis in Lumbar Spinal Stenosis","volume":"34","author":"Netzer","year":"2016","journal-title":"J Orthop Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.38778","article-title":"Structural Associations of Symptomatic Knee Osteoarthritis","volume":"66","author":"Stoppiello","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.783076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T08:04:14Z","timestamp":1646121854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.783076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2022.783076"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.783076","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"article-number":"783076"}}